Carcinoma
Showing 1 - 25 of >10,000
NSCLC, Carcinoma, Renal Cell, Esophageal Squamous Cell Carcinoma Trial (QEQ278)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- +3 more
- QEQ278
- (no location specified)
Jul 14, 2022
Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- PET/CT
- Neck dissection
- (no location specified)
Jan 31, 2023
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)
Not yet recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- (no location specified)
Mar 20, 2023
Advanced Hepatocellular Carcinoma Trial in Shenzhen (GPC3 CAR-T cells)
Recruiting
- Advanced Hepatocellular Carcinoma
- GPC3 CAR-T cells
-
Shenzhen, Guangdong, ChinaLi Yu
Nov 17, 2022
Advanced Hepatocellular Carcinoma Trial in Zhuhai (GDKM-100 injection)
Withdrawn
- Advanced Hepatocellular Carcinoma
- GDKM-100 injection
-
Zhuhai, Guangdong, ChinaZhuhai People'S Hospital
Jan 16, 2023
Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
- Radiotherapy
- Toripalimab
- (no location specified)
Mar 17, 2023
Merkel Cell Carcinoma, Neuroendocrine Carcinoma of the Skin, Trabecular Carcinoma of the Skin Trial in Tampa (Lenvatinib Oral
Recruiting
- Merkel Cell Carcinoma
- +2 more
- Lenvatinib Oral Product
- Pembrolizumab
-
Tampa, FloridaMoffitt Cancer Center
Jul 27, 2022
Key Genes in Hepatocellular Carcinoma
Recruiting
- Hepatocellular Carcinoma
- None of intervention
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 26, 2023
Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma Trial in Lausanne (FLASH RT, Conventional RT)
Not yet recruiting
- Basal Cell Carcinoma
- Cutaneous Squamous Cell Carcinoma
- FLASH RT
- Conventional RT
-
Lausanne, Vaud, SwitzerlandCentre Hospitalier Universitaire Vaudois (CHUV)
Feb 13, 2023
Nasopharyngeal Carcinoma, Recurrent Cancer Trial in Guangzhou (Tranilast)
Recruiting
- Nasopharyngeal Carcinoma
- Recurrent Cancer
-
Guangzhou, Guangdong, ChinaSouthern medical university
Nov 15, 2022
Adrenal Vein Sampling asTool to Identify Biomarkers That Aid
Recruiting
- Adrenocortical Carcinoma
- Blood sampling.
-
Rotterdam, NetherlandsErasmus MC
Dec 14, 2022
Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma Trial in Canton (ACR-368, Gemcitabine,
Recruiting
- Platinum-resistant Ovarian Cancer
- +2 more
- ACR-368
- +2 more
-
Canton, OhioGabrail Cancer Center
Sep 16, 2022
Hepatocellular Carcinoma Trial in Hangzhou (PVE+cTACE+Camrelizumab+Apatinib, cTACE+Atirizumab+Bevacizumab)
Recruiting
- Hepatocellular Carcinoma
- PVE+cTACE+Camrelizumab+Apatinib
- cTACE+Atirizumab+Bevacizumab
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 26, 2023
Vitamin-D Receptor in Laryngeal Squamous Cell Carcinoma
Not yet recruiting
- Laryngeal Carcinoma
- (no location specified)
Jan 16, 2023
Merkel Cell Carcinoma Trial in Philadelphia (Pembrolizumab)
Not yet recruiting
- Merkel Cell Carcinoma
-
Philadelphia, PennsylvaniaPenn Medicine
Aug 9, 2022
Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))
Not yet recruiting
- Renal Cell Carcinoma
- +2 more
- Implantable Microdevice (IMD)
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 17, 2023
Esophageal Squamous Cell Carcinoma Trial (Envafolimab, Albumin-Bound Paclitaxel, Carboplatin)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- Envafolimab
- +2 more
- (no location specified)
Sep 21, 2022
ctDNA-MRD in Predicting Efficacy of Esophageal Squamous Cell
Not yet recruiting
- Squamous Cell Carcinoma of Esophagus
- (no location specified)
Feb 25, 2023
Galectin-3 in Papillary Thyroid Carcinoma
Not yet recruiting
- Galactin 3-thyroid Carcinoma
- (no location specified)
Jan 26, 2023
Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma Trial (BGB-A445, Tislelizumab)
Not yet recruiting
- Urothelial Carcinoma
- +2 more
- (no location specified)
Dec 15, 2022
Advanced Nasopharyngeal Carcinoma Trial in Hangzhou (SBRT)
Recruiting
- Advanced Nasopharyngeal Carcinoma
- SBRT
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Dec 5, 2022
Cutaneous Squamous Cell Carcinoma Staging Study
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- This is not an interventional study
- (no location specified)
Jan 20, 2023
Frequency for Patients With Gastric Neuroendocrine Carcinoma
Completed
- Gastric Neuroendocrine Carcinoma
-
Fuzhou, Fujian, ChinaChang-ming Huang
Dec 31, 2022